JENNIFER KING: Open Payments
NPI 1497301311 · MUSKEGON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 14 payments from 5 companies in 2025. Trend: 2023 $240 · 2024 $353 · 2025 $428
Food & beverage: $428
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $287 |
| Biogen, Inc. | 2 | $52 |
| Merz Pharmaceuticals, LLC | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Genentech USA, Inc. | 1 | $26 |
Products named: QULIPTA, Xeomin, KESIMPTA, ZURZUVAE, Ocrevus Zunovo, TYSABRI.
Industry payments across MI — which companies pay providers there.
